BEAM
Price
$16.47
Change
-$0.38 (-2.26%)
Updated
Aug 29, 12:12 PM (EDT)
Capitalization
1.71B
73 days until earnings call
CCCC
Price
$2.55
Change
-$0.03 (-1.16%)
Updated
Aug 28 closing price
Capitalization
183.62M
62 days until earnings call
Interact to see
Advertisement

BEAM vs CCCC

Header iconBEAM vs CCCC Comparison
Open Charts BEAM vs CCCCBanner chart's image
Beam Therapeutics
Price$16.47
Change-$0.38 (-2.26%)
Volume$2.23K
Capitalization1.71B
C4 Therapeutics
Price$2.55
Change-$0.03 (-1.16%)
Volume$838.59K
Capitalization183.62M
BEAM vs CCCC Comparison Chart in %
Loading...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CCCC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BEAM vs. CCCC commentary
Aug 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEAM is a Buy and CCCC is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 29, 2025
Stock price -- (BEAM: $16.85 vs. CCCC: $2.55)
Brand notoriety: BEAM and CCCC are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BEAM: 72% vs. CCCC: 51%
Market capitalization -- BEAM: $1.71B vs. CCCC: $183.62M
BEAM [@Biotechnology] is valued at $1.71B. CCCC’s [@Biotechnology] market capitalization is $183.62M. The market cap for tickers in the [@Biotechnology] industry ranges from $100.52B to $0. The average market capitalization across the [@Biotechnology] industry is $1.84B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BEAM’s FA Score shows that 1 FA rating(s) are green whileCCCC’s FA Score has 1 green FA rating(s).

  • BEAM’s FA Score: 1 green, 4 red.
  • CCCC’s FA Score: 1 green, 4 red.
According to our system of comparison, CCCC is a better buy in the long-term than BEAM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BEAM’s TA Score shows that 4 TA indicator(s) are bullish while CCCC’s TA Score has 3 bullish TA indicator(s).

  • BEAM’s TA Score: 4 bullish, 5 bearish.
  • CCCC’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, BEAM is a better buy in the short-term than CCCC.

Price Growth

BEAM (@Biotechnology) experienced а +5.25% price change this week, while CCCC (@Biotechnology) price change was -2.30% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.10%. For the same industry, the average monthly price growth was +15.13%, and the average quarterly price growth was +29.20%.

Reported Earning Dates

BEAM is expected to report earnings on Nov 10, 2025.

CCCC is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Biotechnology (-1.10% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BEAM($1.71B) has a higher market cap than CCCC($184M). CCCC YTD gains are higher at: -29.167 vs. BEAM (-32.056). CCCC has higher annual earnings (EBITDA): -109.63M vs. BEAM (-414.33M). BEAM has more cash in the bank: 1.15B vs. CCCC (215M). CCCC has less debt than BEAM: CCCC (62.9M) vs BEAM (155M). BEAM has higher revenues than CCCC: BEAM (60.3M) vs CCCC (34.2M).
BEAMCCCCBEAM / CCCC
Capitalization1.71B184M927%
EBITDA-414.33M-109.63M378%
Gain YTD-32.056-29.167110%
P/E RatioN/AN/A-
Revenue60.3M34.2M176%
Total Cash1.15B215M535%
Total Debt155M62.9M246%
TECHNICAL ANALYSIS
Technical Analysis
BEAMCCCC
RSI
ODDS (%)
Bullish Trend 1 day ago
83%
Bearish Trend 1 day ago
85%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
85%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bearish Trend 1 day ago
82%
Bullish Trend 1 day ago
85%
MACD
ODDS (%)
Bullish Trend 1 day ago
74%
Bearish Trend 1 day ago
88%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
81%
Bearish Trend 1 day ago
88%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
84%
Bullish Trend 1 day ago
86%
Advances
ODDS (%)
Bullish Trend 3 days ago
78%
Bullish Trend 3 days ago
84%
Declines
ODDS (%)
Bearish Trend 9 days ago
85%
Bearish Trend 10 days ago
89%
BollingerBands
ODDS (%)
N/A
Bearish Trend 1 day ago
82%
Aroon
ODDS (%)
Bearish Trend 1 day ago
85%
Bullish Trend 1 day ago
76%
View a ticker or compare two or three
Interact to see
Advertisement
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CCCC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BGIUX15.740.06
+0.36%
Baillie Gifford International Alpha 4
PRHSX79.34N/A
N/A
T. Rowe Price Health Sciences
FSCZX29.10N/A
N/A
Fidelity Advisor Stk Selec Lg Cp Val Z
FIJGX61.74N/A
N/A
Fidelity Advisor Telecommunications Z
KNGAX11.79-0.08
-0.67%
Vest S&P500 Div Aristocrats Trgt Inc A

CCCC and

Correlation & Price change

A.I.dvisor indicates that over the last year, CCCC has been loosely correlated with BEAM. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if CCCC jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CCCC
1D Price
Change %
CCCC100%
-1.16%
BEAM - CCCC
48%
Loosely correlated
-0.06%
SYRE - CCCC
44%
Loosely correlated
-2.45%
OCUL - CCCC
44%
Loosely correlated
+1.62%
MGNX - CCCC
44%
Loosely correlated
-1.16%
KYMR - CCCC
44%
Loosely correlated
-1.21%
More